What is the function of indinavir?
Indinavir is used along with other medications to treat human immunodeficiency virus (HIV) infection. Indinavir is in a class of medications called protease inhibitors. It works by decreasing the amount of HIV in the blood.
What type of inhibitor is Crixivan?
Indinavir (IDV; trade name Crixivan, made by Merck) is a protease inhibitor used as a component of highly active antiretroviral therapy to treat HIV/AIDS. It is soluble white powder administered orally in combination with other antiviral drugs. The drug prevents protease from functioning normally.
How is Crixivan taken?
Indinavir works best if you take it on an empty stomach, at least 1 hour before or 2 hours after a meal. You may also take indinavir with a light meal such as dry toast with jelly, or corn flakes with skim milk and sugar. Avoid eating a high-fat meal. Indinavir is usually taken every 8 hours around the clock.
Is Crixivan still available?
Crixivan (indinavir) was one of the first HIV antiretroviral (ARV) medications approved by the FDA. Due to side effects and medication interactions, it has not been a first choice treatment option for many years and has been discontinued in the U.S.
Is indinavir still used?
Indinavir, a protease inhibitor, is no longer used as part of antiretroviral therapy because of toxicity concerns. Indinavir was FDA-approved in 1996 and, in combination with two nucleoside reverse transcriptase inhibitors (NRTIs), played a major role in the early years of highly active antiretroviral therapy.
What type of inhibitor is indinavir?
Indinavir is a protease inhibitor with activity against Human Immunodeficiency Virus Type 1 (HIV-1). Protease inhibitors block the part of HIV called protease.
What are the side effects of Crixivan?
Common side effects may include:
- stomach pain, nausea, vomiting, diarrhea;
- indigestion, heartburn;
- changes in appetite;
- headache, dizziness, feeling weak or tired;
- back pain;
- rash, itching, dry skin;
- altered sense of taste;
- cold symptoms such as stuffy nose, sneezing, sore throat; or.
What is the generic name for Crixivan?
CRIXIVAN® (indinavir sulfate) is an inhibitor of the human immunodeficiency virus (HIV) protease.
Why was Crixivan discontinued?
“This decision, which was not made lightly, was based on the significant scientific advancements since Crixivan became available, changes to treatment guidelines, and declining demand. The discontinuation is not related to a product quality or safety issue.”
What is the generic name of Crixivan?
Is Humira a painkiller?
Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used to treat certain skin disorders (such as plaque-type psoriasis, hidradenitis suppurativa).
What kind of drug is Crixivan?
Crixivan Description. Crixivan® (indinavir sulfate) is an inhibitor of the human immunodeficiency virus (HIV) protease. Crixivan Capsules are formulated as a sulfate salt and are available for oral administration in strengths of 200 and 400 mg of indinavir (corresponding to 250 and 500 mg indinavir sulfate, respectively).
What is Crixivan (indinavir sulfate)?
In January 1992, researchers synthesized indinavir sulfate (Crixivan), which was assigned compound number L-735,524. They started to test L-735,524 on animals a couple months later and found that it was safe for animals.
Is Crixivan contraindicated with CYP3A4?
Crixivan is contraindicated in patients with clinically significant hypersensitivity to any of its components. Inhibition of CYP3A4 by Crixivan can result in elevated plasma concentrations of the following drugs, potentially causing serious and/or life-threatening reactions: ALERT: Find out about medicines that should NOT be taken with Crixivan.
When was Crixivan first tested on animals?
In January 1992, researchers synthesized indinavir sulfate (Crixivan), which was assigned compound number L-735,524. They started to test L-735,524 on animals a couple months later and found that it was safe for animals. Consequently, the company decided that it was safe to start human trials on September of the same year.
